DB

Dipali Borah

Active Director Director DIN 00966181
DIN 00966181 First appointment Feb 1998 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 1998
Shareholding value •••• Premium profile

About Dipali Borah

Data last updated:

Dipali Borah is a Director at Olwyn Pharma Private Limited (since 1998). The company operates in Pharma. Olwyn Pharma Private Limited reported revenue of ₹21,700 (FY 2022).

DIN 00966181
Primary Designation Director
Industry Pharma
First Appointment 06 Feb 1998
Oldest Company Age 32 yrs
Largest company Olwyn Pharma Private Limited · ₹21,700 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Olwyn Pharma Private Limited U24100AS1994PTC006655
Director06 Feb 19981994₹21,700 (FY 2022)Active

Board colleagues of Dipali Borah

NameDINCompanyDesignation
Pradip Handique00563319Olwyn Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Olwyn Pharma Private Limited
Premium access

Shareholding and investment profile for Dipali Borah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipali Borah

Dipali Borah currently holds 1 directorship: Olwyn Pharma Private Limited (Director, since 06 Feb 1998, revenue ₹21,700 (FY 2022)).

Dipali Borah was first appointed on 06 Feb 1998 as Director at Olwyn Pharma Private Limited.

The current boards of Dipali Borah's companies include Pradip Handique (Olwyn Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available